AURO PHARMA INC, — Sertraline Importer Profile
Pharmaceutical Importer · #12 buyer for Sertraline · $1.7M import value · 54 shipments · CANADA · DGFT Verified
AURO PHARMA INC, is the #12 importer of Sertraline from India with $1.7M in import value and 54 verified shipments. AURO PHARMA INC, holds a 0.5% market share in Sertraline imports based in CANADA. The company sources from 1 verified supplier across 17 formulations shipped to 1 country. Overall, AURO PHARMA INC, imports 11 pharmaceutical products worth $8.9M across 4 therapeutic categories.
AURO PHARMA INC, — Sertraline Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Sertraline to AURO PHARMA INC,?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AUROBINDO PHARMA LIMITED | $1.7M | 54 | 100.0% |
AURO PHARMA INC, sources Sertraline from 1 verified Indian supplier based on 54 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.
How Does AURO PHARMA INC, Compare to Nearest Sertraline Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | GRANULES PHARMACEUTICALS, INC | UNITED STATES | $3.2M | 64 | $50.0K |
| 4 | ORION CORPORATION, | FINLAND | $2.9M | 57 | $50.0K |
| 12 | AURO PHARMA INC, ★ | CANADA | $2.6M | 53 | $50.0K |
| 13 | YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $2.5M | 51 | $50.0K |
| 11 | GRANULES PHARMACEUTICALS INC | UNITED STATES | $2.5M | 50 | $50.0K |
AURO PHARMA INC, ranks #12 among 553 Sertraline importers from India. Average shipment value of $50.0K compared to the market average of $139.5K. The closest competitors by value are GRANULES PHARMACEUTICALS, INC and ORION CORPORATION,.
Where Does AURO PHARMA INC, Import Sertraline To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.7M | 54 | 100.0% |
AURO PHARMA INC, imports Sertraline to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $1.7M.
What Sertraline Formulations Does AURO PHARMA INC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| SERTRALINE 100MG CAPSULES(AURO-SERTRALIN | $397.0K | 12 |
| SERTRALINE CAPSULES 25MG(AURO-SERTRALINE | $318.1K | 12 |
| SERTRALINE CAPSULES 50 MG(AURO-SERTRALIN | $300.0K | 6 |
| SERTRALINE CAPSULES 50 MG (AURO-SERTRALI | $171.4K | 5 |
| SERTRALINE 100MG CAPSULES (AURO-SERTRALI | $126.4K | 6 |
| SERTRALINE 100MG CAPSULES(AURO-SERTRALINE 100)100'S(QTY:29232PAK) | $50.0K | 1 |
| SERTRALINE CAPSULES 25MG (AURO-SERTRALINE 25) 100'S (QTY: 30288 PAK) | $50.0K | 1 |
| SERTRALINE 100MG CAPSULES(AURO-SERTRALINE 100)100'S(QTY:24960PAK) | $50.0K | 1 |
| SERTRALINE 100MG CAPSULES(AURO-SERTRALINE 100)100'S(QTY:25728PAK) | $50.0K | 1 |
| SERTRALINE 100MG CAPSULES (AURO-SERTRALINE 100) (100's) (19800 Packs) | $50.0K | 1 |
AURO PHARMA INC, imports 17 distinct Sertraline formulations from India. The top formulation is SERTRALINE 100MG CAPSULES(AURO-SERTRALIN with 12 shipments worth $397.0K.
Regulatory Requirements: Importing Sertraline into Canada
What AURO PHARMA INC, and other importers must comply with to import Sertraline from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Sertraline
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Sertraline from India and How Much Does AURO PHARMA INC, Import?
India exported $77.1M worth of Sertraline through 5,183 shipments from 218 suppliers to 88 countries, serving 553 buyers globally. AURO PHARMA INC, imports $1.7M of this total, accounting for 0.5% of India's Sertraline exports with 54 shipments from CANADA. This is verified from 54 customs shipment records covering 17 distinct formulations.
What Is the Average Order Value for AURO PHARMA INC,'s Sertraline Imports?
AURO PHARMA INC,'s average Sertraline order value is $31.4K per consignment, based on 54 shipments totaling $1.7M. AURO PHARMA INC, is based in CANADA and ranks #12 among all Sertraline importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Sertraline to AURO PHARMA INC,?
AURO PHARMA INC, sources Sertraline from 1 verified Indian supplier: AUROBINDO PHARMA LIMITED ($1.7M, 100.0%). This is based on 54 customs records.
How Does AURO PHARMA INC, Compare to Other Sertraline Importers?
AURO PHARMA INC, ranks #12 among 553 Sertraline importers from India with a 0.5% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($17.1M), YUSEN LOGISTICS BENELUX BELGIUM ($14.1M), APL SWIFT SERVICES (MALTA) LTD., ($11.8M). AURO PHARMA INC, processed 54 shipments from CANADA.
What Other CNS & Psychiatric Products Does AURO PHARMA INC, Import?
AURO PHARMA INC, also imports these cns & psychiatric products. Each links to the detailed product page.
About AURO PHARMA INC,
AURO PHARMA INC, imports 11 products worth $8.9M. Beyond Sertraline, top products include Cefixime, Dapagliflozin, Escitalopram, Ertapenem, Repaglinide. View the complete AURO PHARMA INC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sertraline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sertraline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AURO PHARMA INC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AURO PHARMA INC,'s capped import value divided by total capped export value for Sertraline across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching AURO PHARMA INC, importing Sertraline, covering 17 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 88+ countries, 553+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sertraline Import Data for AURO PHARMA INC,
Access order-level details, pricing data, supplier connections, and competitive analysis for AURO PHARMA INC,'s Sertraline imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AURO PHARMA INC,
Full Company Profile →
11 products · $8.9M total trade · 4 categories
AURO PHARMA INC, × Sertraline
Verified from customs records
Company Overview
Top Products by AURO PHARMA INC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AURO PHARMA INC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sertraline. For current order-level data, contact TransData Nexus.